Parkinson's disease (PD) is the most common age-related movement disorder, with a prevalence of approximately 2% among people over 65 years of age. The diagnosis of PD is currently based on the clinical manifestations of the disease; therefore, the availability of peripheral biomarkers would have a great impact. In this review, we discuss and compare several attempts made to find peripheral biomarkers of PD to achieve early diagnosis, differential diagnosis, therapy assessment and classification of disease subtypes. Several investigators focused on proteins that are involved in PD pathogenesis. However, the best choice for a sensible biomarker-discovery procedure makes use of global approaches such as metabolornics and proteomics. In addition, the tissue or compartment where biomarkers are located, plays a basic role. In this context, lymphocytes are of particular interest because they are circulating dopaminergic cells, and display several functional modifications in PD. © 2008 Future Medicine Ltd.

Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration

FASANO, MAURO;ALBERIO, TIZIANA;
2008-01-01

Abstract

Parkinson's disease (PD) is the most common age-related movement disorder, with a prevalence of approximately 2% among people over 65 years of age. The diagnosis of PD is currently based on the clinical manifestations of the disease; therefore, the availability of peripheral biomarkers would have a great impact. In this review, we discuss and compare several attempts made to find peripheral biomarkers of PD to achieve early diagnosis, differential diagnosis, therapy assessment and classification of disease subtypes. Several investigators focused on proteins that are involved in PD pathogenesis. However, the best choice for a sensible biomarker-discovery procedure makes use of global approaches such as metabolornics and proteomics. In addition, the tissue or compartment where biomarkers are located, plays a basic role. In this context, lymphocytes are of particular interest because they are circulating dopaminergic cells, and display several functional modifications in PD. © 2008 Future Medicine Ltd.
2008
http://www.futuremedicine.com/doi/pdf/10.2217/17520363.2.5.465
α-synuclein; Biomaker discovery; Parkinson's disease; Peripheral blood lymphocytes; Proteomics;
Fasano, Mauro; Alberio, Tiziana; Lopiano, L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/13625
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 17
social impact